There’s a race to get 2 revolutionary new cancer treatments on the market — here’s who’s in the lead – Business Insider
Business Insider |
There's a race to get 2 revolutionary new cancer treatments on the market — here's who's in the lead
Business Insider Short for chimeric antigen receptor T–cell therapy, CAR-T treatment takes a person's own cells, removes them from the body, re-engineers them, and then puts the cells back in the body where they can attack cancer cells. There are a handful of companies … Novartis' CAR–T shows durable response in lymphoma patients Small Biotech Pops As Rival Novartis Struggles To Keep Pace Novartis's Next Challenge: Pricing Breakthrough Cancer Treatment |
